Deakin University   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Victoria Australia (1974)

Organization Overview

First Clinical Trial
2006
NCT00528710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Deakin University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Fibromyalgia (Phase 2)

Malaria (Phase 1)

Malaria, Falciparum (Phase 1)

Myofascial Pain Syndromes (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 11